"Gomperts first launched Aid Access in 2018, more than a decade after starting Women on Web, a similar service for people who live in countries where abortion is illegal. Women who log onto Aid Access are screened online for their eligibility for medication abortions. (If they’re more than nine weeks pregnant, the pills may not work.)
Gomperts consults with prospective patients remotely, then fills their prescriptions for misoprostol and mifepristone. The abortion-causing pills are ultimately shipped to the United States by an India-based pharmacy.
...
In October 2018, the FDA announced that it was investigating Aid Access. Six months later, the FDA sent Gomperts a letter, warning her that the agency had determined she introduced “misbranded and unapproved new drugs” into the United States. This violates the Federal Food, Drug, and Cosmetic Act, according to the FDA."
Gomperts consults with prospective patients remotely, then fills their prescriptions for misoprostol and mifepristone. The abortion-causing pills are ultimately shipped to the United States by an India-based pharmacy.
...
In October 2018, the FDA announced that it was investigating Aid Access. Six months later, the FDA sent Gomperts a letter, warning her that the agency had determined she introduced “misbranded and unapproved new drugs” into the United States. This violates the Federal Food, Drug, and Cosmetic Act, according to the FDA."